DailyStocks Stock Article Search

https://seekingalpha.com/news/4103984-bluebird-bio-stock-gains-q1-2024-results?source=feed_sector_healthcare May 09, 2024 - Bluebird bio (BLUE) stock rises as Q1 financials exceed expectations despite lagging behind CRISPR Therapeutics (CRSP) in gene therapy rollout. Read more here. 0

https://seekingalpha.com/news/4102636-gritstone-bio-q1-2024-earnings-preview?source=feed_sector_healthcare May 08, 2024 - Gritstone bio (GRTS) is set to announce Q1 earnings results, with a consensus EPS estimate of -$0.31 and a revenue estimate of $2.85M (+16.8% Y/Y). 0

https://seekingalpha.com/article/4690550-bio-rad-laboratories-inc-bio-q1-2024-earnings-call-transcript?source=feed_sector_transcripts May 07, 2024 - Bio-Rad Laboratories, Inc. (NYSE:NYSE:BIO) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ETCompany ParticipantsEdward Chung - Head, Investor... 0

https://seekingalpha.com/article/4688345-annovis-bio-alzheimer-phase-2-3-topline-readout-puts-buntanetap-future-into-question?source=feed_all_articles May 01, 2024 - Annovis faces financial challenges and may see a significant decline in stock prices. Find out why ANVS stock is a Sell. 0

https://seekingalpha.com/news/4096265-inmune-bio-provides-update-alzheimers-candidate-xpro?source=feed_sector_healthcare Apr 30, 2024 - INmune Bio's experimental Alzheimer's treatment XPro shows promising results in stabilizing cognitive states of patients in compassionate use program. Read more here. 0

https://seekingalpha.com/news/4095540-annovis-bio-alzheimers-tumbles-53-data-alzheimers-candidate-buntanetap?source=feed_sector_healthcare Apr 29, 2024 - Annovis Bio&amp;#39;s Alzheimers disease candidate, buntanetap, triggers trading halts as shares fall ~53%, indicating potential disappointment in trial results. Read more here 0

https://www.zacks.com/stock/news/2263665/entera-bio-ltd-entx-stock-slides-as-market-rises-facts-to-know-before-you-trade?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2263665 Apr 26, 2024 - The latest trading day saw Entera Bio Ltd. (ENTX) settling at $1.98, representing a -1% change from its previous close. 0

https://seekingalpha.com/news/4094442-takeda-leaves-industry-trade-group-bio?source=feed_sector_healthcare Apr 25, 2024 - Takeda Pharmaceutical (TAK) joins Pfizer (PFE) in leaving the Biotechnology Innovation Organization, the top biotech lobbying group. Read more here. 0

https://www.zacks.com/stock/news/2258103/why-the-market-dipped-but-entera-bio-ltd-entx-gained-today?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2258103 Apr 18, 2024 - In the closing of the recent trading day, Entera Bio Ltd. (ENTX) stood at $2.24, denoting a +0.9% change from the preceding trading day. 0

https://seekingalpha.com/news/4091115-telesis-bio-stock-slips-amid-new-ceo?source=feed_sector_healthcare Apr 18, 2024 - Telesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here. 0